TY - JOUR AU - Blijlevens, N. M. PY - 2005 DA - 2005// TI - Implications of treatment-induced mucosal barrier injury JO - Curr Opin Oncol VL - 17 ID - Blijlevens2005 ER - TY - JOUR AU - Vera-Llonch, M. AU - Oster, G. AU - Ford, C. M. AU - Lu, J. AU - Sonis, S. PY - 2007 DA - 2007// TI - Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies JO - Support Care Cancer VL - 15 UR - https://doi.org/10.1007/s00520-006-0176-9 DO - 10.1007/s00520-006-0176-9 ID - Vera-Llonch2007 ER - TY - JOUR AU - Auletta, J. J. AU - Lazarus, H. M. PY - 2005 DA - 2005// TI - Immune restoration following hematopoietic stem cell transplantation: an evolving target JO - Bone Marrow Transplant VL - 35 UR - https://doi.org/10.1038/sj.bmt.1704966 DO - 10.1038/sj.bmt.1704966 ID - Auletta2005 ER - TY - JOUR AU - Gratwohl, A. AU - Brand, R. AU - Frassoni, F. AU - Rocha, V. AU - Niederwieser, D. AU - Reusser, P. AU - Einsele, H. AU - Cordonnier, C. PY - 2005 DA - 2005// TI - Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time JO - Bone Marrow Transplant VL - 36 UR - https://doi.org/10.1038/sj.bmt.1705140 DO - 10.1038/sj.bmt.1705140 ID - Gratwohl2005 ER - TY - JOUR AU - Schots, R. AU - Kaufman, L. AU - Van, R. I. AU - Ben, O. T. AU - De, W. M. AU - Van, C. B. AU - Demanet, C. PY - 2003 DA - 2003// TI - Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation JO - Leukemia VL - 17 UR - https://doi.org/10.1038/sj.leu.2402946 DO - 10.1038/sj.leu.2402946 ID - Schots2003 ER - TY - JOUR AU - Robicsek, A. AU - Jacoby, G. A. AU - Hooper, D. C. PY - 2006 DA - 2006// TI - The worldwide emergence of plasmid-mediated quinolone resistance JO - Lancet Infect Dis VL - 6 UR - https://doi.org/10.1016/S1473-3099(06)70599-0 DO - 10.1016/S1473-3099(06)70599-0 ID - Robicsek2006 ER - TY - JOUR AU - Snelders, E. AU - Lee, H. A. v. a. n. d. e. r. AU - Kuijpers, J. AU - Rijs, A. J. AU - Varga, J. AU - Samson, R. A. AU - Mellado, E. AU - Donders, A. R. AU - Melchers, W. J. AU - Verweij, P. E. PY - 2008 DA - 2008// TI - Emergence of azole resistance in Aspergillus fumigatusand spread of a single resistance mechanism JO - PLoS Med VL - 5 UR - https://doi.org/10.1371/journal.pmed.0050219 DO - 10.1371/journal.pmed.0050219 ID - Snelders2008 ER - TY - JOUR AU - Arias, C. A. AU - Murray, B. E. PY - 2009 DA - 2009// TI - Antibiotic-resistant bugs in the 21st century - a clinical super-challenge JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMp0804651 DO - 10.1056/NEJMp0804651 ID - Arias2009 ER - TY - JOUR AU - Mookherjee, N. AU - Hancock, R. E. PY - 2007 DA - 2007// TI - Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections JO - Cell Mol Life Sci VL - 64 UR - https://doi.org/10.1007/s00018-007-6475-6 DO - 10.1007/s00018-007-6475-6 ID - Mookherjee2007 ER - TY - JOUR AU - Hancock, R. E. AU - Patrzykat, A. PY - 2002 DA - 2002// TI - Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics JO - Curr Drug Targets Infect Disord VL - 2 UR - https://doi.org/10.2174/1568005024605855 DO - 10.2174/1568005024605855 ID - Hancock2002 ER - TY - JOUR AU - Zasloff, M. PY - 2002 DA - 2002// TI - Antimicrobial peptides of multicellular organisms JO - Nature VL - 415 UR - https://doi.org/10.1038/415389a DO - 10.1038/415389a ID - Zasloff2002 ER - TY - JOUR AU - Masson, P. L. AU - Heremans, J. F. AU - Schonne, E. PY - 1969 DA - 1969// TI - Lactoferrin, an iron-binding protein in neutrophilic leukocytes JO - J Exp Med VL - 130 UR - https://doi.org/10.1084/jem.130.3.643 DO - 10.1084/jem.130.3.643 ID - Masson1969 ER - TY - JOUR AU - Masson, P. L. PY - 1966 DA - 1966// TI - An iron-binding protein common to many external secretions JO - Clinica Chimica Acta VL - 14 UR - https://doi.org/10.1016/0009-8981(66)90004-0 DO - 10.1016/0009-8981(66)90004-0 ID - Masson1966 ER - TY - JOUR AU - Legrand, D. AU - Elass, E. AU - Carpentier, M. AU - Mazurier, J. PY - 2005 DA - 2005// TI - Lactoferrin: a modulator of immune and inflammatory responses JO - Cell Mol Life Sci VL - 62 UR - https://doi.org/10.1007/s00018-005-5370-2 DO - 10.1007/s00018-005-5370-2 ID - Legrand2005 ER - TY - JOUR AU - Gifford, J. L. AU - Hunter, H. N. AU - Vogel, H. J. PY - 2005 DA - 2005// TI - Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties JO - Cell Mol Life Sci VL - 62 UR - https://doi.org/10.1007/s00018-005-5373-z DO - 10.1007/s00018-005-5373-z ID - Gifford2005 ER - TY - JOUR AU - Valenti, P. AU - Antonini, G. PY - 2005 DA - 2005// TI - Lactoferrin: an important host defence against microbial and viral attack JO - Cell Mol Life Sci VL - 62 UR - https://doi.org/10.1007/s00018-005-5372-0 DO - 10.1007/s00018-005-5372-0 ID - Valenti2005 ER - TY - JOUR AU - Ward, P. P. AU - Paz, E. AU - Conneely, O. M. PY - 2005 DA - 2005// TI - Multifunctional roles of lactoferrin: a critical overview JO - Cell Mol Life Sci VL - 62 UR - https://doi.org/10.1007/s00018-005-5369-8 DO - 10.1007/s00018-005-5369-8 ID - Ward2005 ER - TY - JOUR AU - Suzuki, T. AU - Takizawa-Mizuno, M. AU - Yazaki, M. AU - Wada, Y. AU - Asai, K. AU - Kato, T. PY - 1991 DA - 1991// TI - Plasma lactoferrin levels after bone marrow transplantation monitored by a two-site enzyme immunoassay JO - Clin Chim Acta VL - 202 UR - https://doi.org/10.1016/0009-8981(91)90262-B DO - 10.1016/0009-8981(91)90262-B ID - Suzuki1991 ER - TY - JOUR AU - Velden, W. J. F. M. v. a. n. d. e. r. AU - Blijlevens, N. M. AU - Donnelly, J. P. PY - 2008 DA - 2008// TI - The potential role of lactoferrin and derivatives in the management of infectious and inflammatory complications of hematology patients receiving a hematopoietic stem cell transplantation JO - Transpl Infect Dis VL - 10 UR - https://doi.org/10.1111/j.1399-3062.2007.00260.x DO - 10.1111/j.1399-3062.2007.00260.x ID - Velden2008 ER - TY - JOUR AU - Faber, C. AU - Stallmann, H. P. AU - Lyaruu, D. M. AU - Joosten, U. AU - von, E. C. AU - van Nieuw, A. A. AU - Wuisman, P. I. PY - 2005 DA - 2005// TI - Comparable efficacies of the antimicrobial peptide human lactoferrin 1-11 and gentamicin in a chronic methicillin-resistant Staphylococcus aureusosteomyelitis model JO - Antimicrob Agents Chemother VL - 49 UR - https://doi.org/10.1128/AAC.49.6.2438-2444.2005 DO - 10.1128/AAC.49.6.2438-2444.2005 ID - Faber2005 ER - TY - JOUR AU - Lupetti, A. AU - Paulusma-Annema, A. AU - Welling, M. M. AU - Senesi, S. AU - Van Dissel, J. T. AU - Nibbering, P. H. PY - 2000 DA - 2000// TI - Candidacidal activities of human lactoferrin peptides derived from the N terminus JO - Antimicrob Agents Chemother VL - 44 UR - https://doi.org/10.1128/AAC.44.12.3257-3263.2000 DO - 10.1128/AAC.44.12.3257-3263.2000 ID - Lupetti2000 ER - TY - JOUR AU - Lupetti, A. AU - Brouwer, C. P. AU - Bogaards, S. J. AU - Welling, M. M. AU - de, H. E. AU - Campa, M. AU - Van Dissel, J. T. AU - Friesen, R. H. AU - Nibbering, P. H. PY - 2007 DA - 2007// TI - Human lactoferrin-derived peptide's antifungal activities against disseminated Candida albicansinfection JO - J Infect Dis VL - 196 UR - https://doi.org/10.1086/522427 DO - 10.1086/522427 ID - Lupetti2007 ER - TY - JOUR AU - Stallmann, H. P. AU - Faber, C. AU - Bronckers, A. L. AU - Nieuw Amerongen, A. V. AU - Wuisman, P. I. PY - 2004 DA - 2004// TI - Osteomyelitis prevention in rabbits using antimicrobial peptide hLF1-11- or gentamicin-containing calcium phosphate cement JO - J Antimicrob Chemother VL - 54 UR - https://doi.org/10.1093/jac/dkh346 DO - 10.1093/jac/dkh346 ID - Stallmann2004 ER - TY - JOUR AU - Dijkshoorn, L. AU - Brouwer, C. P. AU - Bogaards, S. J. AU - Nemec, A. AU - Broek, P. J. v. a. n. d. e. n. AU - Nibbering, P. H. PY - 2004 DA - 2004// TI - The synthetic N-terminal peptide of human lactoferrin, hLF(1-11), is highly effective against experimental infection caused by multidrug-resistant Acinetobacter baumannii JO - Antimicrob Agents Chemother VL - 48 UR - https://doi.org/10.1128/AAC.48.12.4919-4921.2004 DO - 10.1128/AAC.48.12.4919-4921.2004 ID - Dijkshoorn2004 ER - TY - JOUR PY - 1997 DA - 1997// TI - World Health Organization International Conference on Harmonization JO - Topic E6: Guidelines for Good Clincial Practice. US Federal Register VL - 62 ID - ref25 ER - TY - STD TI - Cancer Therapy Evaluation Program: Common Terminology Criteria for Adverse Events, Version 3.0. [http://ctep.cancer.gov] UR - http://ctep.cancer.gov ID - ref26 ER - TY - JOUR AU - Neuburger, S. AU - Maschmeyer, G. PY - 2006 DA - 2006// TI - Update on management of infections in cancer and stem cell transplant patients JO - Ann Hematol VL - 85 UR - https://doi.org/10.1007/s00277-005-0048-2 DO - 10.1007/s00277-005-0048-2 ID - Neuburger2006 ER - TY - JOUR AU - van Berkel, P. H. AU - Geerts, M. E. AU - van Veen, H. A. AU - Mericskay, M. AU - de Boer, H. A. AU - Nuijens, J. H. PY - 1997 DA - 1997// TI - N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA JO - Biochem J VL - 328 UR - https://doi.org/10.1042/bj3280145 DO - 10.1042/bj3280145 ID - van Berkel1997 ER - TY - JOUR AU - Legrand, D. AU - van Berkel, P. H. AU - Salmon, V. AU - van Veen, H. A. AU - Slomianny, M. C. AU - Nuijens, J. H. AU - Spik, G. PY - 1997 DA - 1997// TI - The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells JO - Biochem J VL - 327 UR - https://doi.org/10.1042/bj3270841 DO - 10.1042/bj3270841 ID - Legrand1997 ER - TY - JOUR AU - Ellison, R. T. PY - 1994 DA - 1994// TI - The effects of lactoferrin on Gram-negative bacteria JO - Adv Exp Med Biol VL - 357 UR - https://doi.org/10.1007/978-1-4615-2548-6_8 DO - 10.1007/978-1-4615-2548-6_8 ID - Ellison1994 ER - TY - JOUR AU - Wakabayashi, H. AU - Takakura, N. AU - Teraguchi, S. AU - Tamura, Y. PY - 2003 DA - 2003// TI - Lactoferrin feeding augments peritoneal macrophage activities in mice intraperitoneally injected with inactivated Candida albicans JO - Microbiol Immunol VL - 47 UR - https://doi.org/10.1111/j.1348-0421.2003.tb02783.x DO - 10.1111/j.1348-0421.2003.tb02783.x ID - Wakabayashi2003 ER - TY - JOUR AU - Miyauchi, H. AU - Hashimoto, S. AU - Nakajima, M. AU - Shinoda, I. AU - Fukuwatari, Y. AU - Hayasawa, H. PY - 1998 DA - 1998// TI - Bovine lactoferrin stimulates the phagocytic activity of human neutrophils: identification of its active domain JO - Cell Immunol VL - 187 UR - https://doi.org/10.1006/cimm.1997.1246 DO - 10.1006/cimm.1997.1246 ID - Miyauchi1998 ER - TY - JOUR AU - Szuster-Ciesielska, A. AU - Kaminska, T. AU - Kandefer-Szerszen, M. PY - 1995 DA - 1995// TI - Phagocytosis-enhancing effect of lactoferrin on bovine peripheral blood monocytes in vitro and in vivo JO - Arch Vet Pol VL - 35 ID - Szuster-Ciesielska1995 ER - TY - JOUR AU - Legrand, D. AU - Elass, E. AU - Carpentier, M. AU - Mazurier, J. PY - 2006 DA - 2006// TI - Interactions of lactoferrin with cells involved in immune function JO - Biochem Cell Biol VL - 84 UR - https://doi.org/10.1139/o06-045 DO - 10.1139/o06-045 ID - Legrand2006 ER - TY - JOUR AU - Elass-Rochard, E. AU - Legrand, D. AU - Salmon, V. AU - Roseanu, A. AU - Trif, M. AU - Tobias, P. S. AU - Mazurier, J. AU - Spik, G. PY - 1998 DA - 1998// TI - Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein JO - Infect Immun VL - 66 ID - Elass-Rochard1998 ER - TY - JOUR AU - Haversen, L. AU - Ohlsson, B. G. AU - Hahn-Zoric, M. AU - Hanson, L. A. AU - Mattsby-Baltzer, I. PY - 2002 DA - 2002// TI - Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappa B JO - Cell Immunol VL - 220 UR - https://doi.org/10.1016/S0008-8749(03)00006-6 DO - 10.1016/S0008-8749(03)00006-6 ID - Haversen2002 ER - TY - JOUR AU - Nibbering, P. H. AU - Ravensbergen, E. AU - Welling, M. M. AU - van Berkel, L. A. AU - van Berkel, P. H. AU - Pauwels, E. K. AU - Nuijens, J. H. PY - 2001 DA - 2001// TI - Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria JO - Infect Immun VL - 69 UR - https://doi.org/10.1128/IAI.69.3.1469-1476.2001 DO - 10.1128/IAI.69.3.1469-1476.2001 ID - Nibbering2001 ER - TY - JOUR AU - Lupetti, A. AU - Paulusma-Annema, A. AU - Welling, M. M. AU - Dogterom-Ballering, H. AU - Brouwer, C. P. AU - Senesi, S. AU - Van Dissel, J. T. AU - Nibbering, P. H. PY - 2003 DA - 2003// TI - Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candidaspecies JO - Antimicrob Agents Chemother VL - 47 UR - https://doi.org/10.1128/AAC.47.1.262-267.2003 DO - 10.1128/AAC.47.1.262-267.2003 ID - Lupetti2003 ER - TY - JOUR AU - Stallmann, H. P. AU - Faber, C. AU - Bronckers, A. L. AU - de Blieck-Hogervorst, J. M. AU - Brouwer, C. P. AU - Amerongen, A. V. AU - Wuisman, P. I. PY - 2005 DA - 2005// TI - Histatin and lactoferrin derived peptides: antimicrobial properties and effects on mammalian cells JO - Peptides VL - 26 UR - https://doi.org/10.1016/j.peptides.2005.05.014 DO - 10.1016/j.peptides.2005.05.014 ID - Stallmann2005 ER - TY - JOUR AU - Melo, M. N. AU - Ferre, R. AU - Castanho, M. A. PY - 2009 DA - 2009// TI - Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations JO - Nat Rev Microbiol VL - 7 UR - https://doi.org/10.1038/nrmicro2095 DO - 10.1038/nrmicro2095 ID - Melo2009 ER - TY - JOUR AU - Durie, B. G. AU - Salmon, S. E. PY - 1975 DA - 1975// TI - A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival JO - Cancer VL - 36 UR - https://doi.org/3.0.CO;2-U DO - 3.0.CO;2-U ID - Durie1975 ER - TY - JOUR AU - Blade, J. AU - Samson, D. AU - Reece, D. AU - Apperley, J. AU - Bjorkstrand, B. AU - Gahrton, G. AU - Gertz, M. AU - Giralt, S. AU - Jagannath, S. AU - Vesole, D. PY - 1998 DA - 1998// TI - Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant JO - Br J Haematol VL - 102 UR - https://doi.org/10.1046/j.1365-2141.1998.00930.x DO - 10.1046/j.1365-2141.1998.00930.x ID - Blade1998 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1741-7015/7/44/prepub UR - http://www.biomedcentral.com/1741-7015/7/44/prepub ID - ref43 ER -